Clinical Trial Update: Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, tolerability, immunogenicity, and protective efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian adults with naturally t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)
• PfSPZ-CVac (PfSPZ-CVac)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria | Phase 2 | Status: COMPLETED